Moderna, Inc. (MRNA)

Moderna Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,132	1,927	2,907	3,205	6,848	2,624
Short-Term Investments	3,372	5,098	5,697	6,697	3,879	1,984
Cash & Short-Term Investments	4,504	7,025	8,604	9,902	10,727	4,608
Cash Growth	-34.41%	-18.35%	-13.11%	-7.69%	132.79%	317.77%
Accounts Receivable	1,046	358	892	1,385	3,175	1,391
Other Receivables	-	234	189	264	148	17
Receivables	1,046	592	1,081	1,685	3,323	1,408
Inventory	332	117	202	1,168	1,728	47
Prepaid Expenses	716	173	182	254	126	7
Restricted Cash	-	-	-	-	-	1
Other Current Assets	-	192	256	422	167	227
Total Current Assets	6,598	8,099	10,325	13,431	16,071	6,298
Property, Plant & Equipment	2,864	2,955	2,658	2,139	1,383	387
Long-Term Investments	2,143	2,508	4,743	8,360	6,843	639
Goodwill	-	52	52	-	-	-
Other Intangible Assets	-	40	44	-	-	-
Long-Term Deferred Tax Assets	-	-	-	982	326	-
Other Long-Term Assets	530	488	604	946	46	13
Total Assets	12,135	14,142	18,426	25,858	24,669	7,337
Accounts Payable	267	405	520	487	302	18
Accrued Expenses	1,178	898	1,069	1,828	1,472	470
Current Portion of Leases	-	37	25	196	211	30
Current Income Taxes Payable	-	-	-	48	876	-
Current Unearned Revenue	163	153	568	2,038	6,253	3,867
Other Current Liabilities	73	713	833	326	14	4
Total Current Liabilities	1,681	2,206	3,015	4,923	9,128	4,389
Long-Term Leases	686	710	1,218	1,004	705	207
Long-Term Unearned Revenue	157	58	83	673	615	177
Other Long-Term Liabilities	281	267	256	135	76	3
Total Liabilities	2,805	3,241	4,572	6,735	10,524	4,776
Additional Paid-In Capital	1,254	866	371	1,173	4,211	4,802
Retained Earnings	8,049	10,045	13,606	18,320	9,958	-2,244
Comprehensive Income & Other	27	-10	-123	-370	-24	3
Total Common Equity	9,330	10,901	13,854	19,123	14,145	2,561
Shareholders' Equity	9,330	10,901	13,854	19,123	14,145	2,561
Total Liabilities & Equity	12,135	14,142	18,426	25,858	24,669	7,337
Total Debt	686	747	1,243	1,200	916	237
Net Cash (Debt)	5,961	8,772	12,038	17,020	16,654	5,010
Net Cash Growth	-24.04%	-27.13%	-29.27%	2.20%	232.41%	418.07%
Net Cash Per Share	15.37	22.84	31.51	40.91	38.64	13.15
Filing Date Shares Outstanding	390	385.82	382.07	386.34	402.87	399.77
Total Common Shares Outstanding	390	386	382	385	403	398.79
Working Capital	4,917	5,893	7,310	8,508	6,943	1,909
Book Value Per Share	23.92	28.24	36.27	49.67	35.10	6.42
Tangible Book Value	9,330	10,809	13,758	19,123	14,145	2,561
Tangible Book Value Per Share	23.92	28.00	36.02	49.67	35.10	6.42
Land	-	59	22	11	-	-
Buildings	-	743	-	-	-	-
Machinery	-	525	445	343	211	139
Construction In Progress	-	1,057	860	281	212	35
Leasehold Improvements	-	207	522	460	313	180

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q